Blog
RSS FeedPosted by Michael Wonder on 13 Aug 2018
Melbourne man spends $80,000 on the miracle cancer drug that saved his life
13 August 2018 - Diagnosed with Stage 4 lung cancer in 2017, John Burke should, in his words, be “gone ...
Posted by Michael Wonder on 10 Aug 2018
August 2018 PBAC special meeting – public submissions now available
10 August 2018 - Public submissions to the August 2018 PBAC meeting regarding PD-1 and PD-L1 checkpoint inhibitor immunotherapies: options for ...
Posted by Michael Wonder on 31 Jul 2018
MAESTrO Snapshot - August 2018
1 August 2018 - The second issue looks at today's listing of nivolumab (Opdivo) on the PBS for the treatment ...
Posted by Michael Wonder on 28 Jul 2018
PBS listing puts Opdivo within financial reach of cancer patients
27 July 2018 - Australians with head and neck cancer will from next week have affordable access to an immuno-oncology ...
Posted by Michael Wonder on 16 Jul 2018
$250 million investment in life changing cancer medicines
15 July 2018 - The Australian Government will invest $250 million to make four life-changing cancer medicines available to thousands of ...
Posted by Michael Wonder on 15 Jul 2018
Life-saving drug subsidies for thousands of patients battling rare cancers
15 July 2018 - When dietitian Nathalie Cook discovered she had a rare blood cancer almost a decade ago, the ...
Posted by Michael Wonder on 08 Jul 2018
ACT cancer patients have been slugged with an unfair fee. Until now.
3 July 2018 - The ACT Government has promised to scrap the chemotherapy co-payment ACT cancer patients are "unfairly" slugged ...
Posted by Michael Wonder on 01 Jul 2018
A drug that elongates life in breast cancer patients listed on PBS today - but only for some
1 July 2018 - They are two women from the same city who have exactly the same deadly disease. ...
Posted by Michael Wonder on 30 Jun 2018
Price of breast cancer drug ribociclib cut after being placed on Pharmaceutical Benefits Scheme
30 June 2018 - The breast cancer drug ribociclib has been placed on the Pharmaceutical Benefits Scheme, taking the price from ...
Posted by Michael Wonder on 25 Jun 2018
PBS push for stage-three melanoma drug
25 June 2018 - After witnessing family members succumb to cancer, Melbourne man Peter Gourlay was determined to do whatever ...
Posted by Michael Wonder on 22 Jun 2018
Bob Katter wants Keytruda added to PBS
22 June 2018 - With breast cancer and Hodgkin lymphoma drugs added to the Pharmaceutical Benefits Scheme Kennedy MP Bob ...
Posted by Michael Wonder on 21 Jun 2018
Australian Stage 3 melanoma patients forced to self-fund recurrent treatment while PBS makes decision on listing
21 June 2018 - An Australian man has described the staggering decision to pay $100,000 for a treatment that could mean ...
Posted by Michael Wonder on 04 Jun 2018
Rule out chemotherapy for early breast cancer - but first take a $5,000 test
4 June 2018 - There is good news for women with early breast cancer, but for Australians it comes at ...
Posted by Michael Wonder on 28 May 2018
Cancer-killing CAR T-cell immunotherapy to become more accessible to patients
29 May 2018 - Cancer patients would have access to an off-the-shelf immunotherapies to reprogram their immune system to fight ...
Posted by Michael Wonder on 24 May 2018
New melanoma guidelines recommend $150,000 a year treatment that’s not subsidised
25 May 2018 - Sweeping changes to medical guidelines for melanoma could halve the rate at which the cancer recurs ...